| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee2b0256bf53495400ed438da3da663c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
| filingDate |
2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a056c1ef12916cf136e4800c0952960b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e26bd84b99febdb79efd4fb3649f11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4962633ff3121e5af13e0789e606ee9 |
| publicationDate |
2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020002650-A1 |
| titleOfInvention |
A formulation |
| abstract |
There is disclosed a formulation comprising a GM-CSF protein having at least 60% sequence identity to the polypeptide sequence of SEQ ID NO: 2. The formulation comprises a stabiliser, wherein the stabiliser comprises a poloxamer present in an amount of 0.5-3.0wt%, excluding water. The formulation does not comprise more than 0.2wt%of human serum albumin or recombinant human albumin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021185921-A1 |
| priorityDate |
2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |